HOME >> BIOLOGY >> NEWS
JCI table of contents: April 12, 2007

EDITOR'S PICK: Two heads are better than one: two dysfunctional DNA repair pathways kill tumor cells

Individuals who inherit two mutant copies of any one of about 12 genes that make the proteins of the Fanconi Anemia (FA) pathway develop FA, which is characterized by increased incidence of cancer and bone marrow failure, among other things. However, individuals with just a single mutant copy of one of these genes are also at increased risk of developing cancer. This occurs when the remaining "good" copy of the gene becomes mutated in a specific cell type, allowing that cell type to form a tumor. However, hope of a new treatment for these cancers has now been provided by researchers from the Dana-Farber Cancer Institute in Boston who suggest that inhibiting the protein ATM might kill these cancer cells.

In the study, which appears online on April 12 in advance of publication in the May print issue of the Journal of Clinical Investigation, Alan D'Andrea and colleagues show that loss of ATM function in human cell lines with a dysfunctional FA pathway caused the cells to die. The dying cells were characterized by high levels of DNA breakage, which is consistent with the fact that FA pathway proteins and ATM are important regulators of two distinct DNA repair pathways. It therefore seems that the ATM pathway of DNA repair keeps the FA pathwaydeficient tumor cells alive and that loss of this pathway results in tumor cell death. As FA pathwaydeficient tumor cells were shown to be sensitive to an inhibitor of ATM, the authors suggest that ATM might provide a therapeutic target for the treatment of individuals with FA pathwaydeficient tumors.

TITLE: Fanconi anemia pathwaydeficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated

AUTHOR CONTACT:
Alan D. D'Andrea
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Phone: (617) 632-2112; Fax: (617) 63
'"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
12-Apr-2007


Page: 1 2 3 4 5 6

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. JCI table of contents: June 14, 2007
11. Food safety begins as vegetables grow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2018)... Calif. (PRWEB) , ... September 10, 2018 , ... ... a paper detailing the performance of its new Multiplexed Ion Beam Imaging (MIBITM) ... September 6 issue. This study will also be shared during a webinar presented ...
(Date:9/7/2018)... ... September 05, 2018 , ... ... mAb manufacturing facility late last year, IPS-Integrated Project Services, LLC and G-CON Manufacturing ... autologous cell therapies. The iCON solution provides a pre-fabricated modular cleanroom infrastructure for ...
(Date:8/31/2018)... , ... August 30, 2018 , ... ... offering a complimentary cryogenic freezer program for new clients. The freezers are very ... regenerative biologics from R3 Stem Cell consist of amniotic and umbilical cord tissue. ...
Breaking Biology News(10 mins):
(Date:8/31/2018)... ... August 30, 2018 , ... Small, wireless and networked describes more than the ... connected, too. Draper’s latest system is tiny in size, but is poised to make ... in the new implant design is the growing awareness that disease often involves complex ...
(Date:8/29/2018)... Calif. (PRWEB) , ... August 28, 2018 , ... ... scientists from around the world, is proud to announce the launch of a new ... offers for a chance to win one of LabRoots most popular shirts. , Throughout ...
(Date:8/23/2018)... ... August 23, 2018 , ... Visikol began ... Dr. Thomas Villani. Through support from advisors, mentors, the Rutgers Technology Transfer team and ... Visikol’s path from an idea to a successful biotech company has been a circuitous ...
(Date:8/17/2018)... (PRWEB) , ... August 16, 2018 , ... ... testing, announced their results from the AmbryShare project were published today in JAMA ... in the largest exome study ever conducted. , Every year hereditary breast cancer ...
Breaking Biology Technology:
Cached News: